Free Newsletter
Revolutionary stem cell trials planned in the UK
A group of British doctors are preparing for human clinical trials that will take a person's bone marrow stem cells, transform them into heart stem cells and inject them into the heart, where they can go to work repairing damage.
"Placing heart stem cells into the heart to repair has a very good chance of working; because the stem cells are the patient's own there are no problems with rejection," said Professor Sian Harding, of Imperial College London.
The British researchers plan to use a technique that was pioneered at the Mayo Clinic. They will remove 40 milliliters of bone marrow from a patient and then grow heart stem cells from them through the use of growth factors. Once injected back into the heart, doctors say they can expect a physical improvement in the patient in as little as two weeks.
"Human heart stem cells repaired damaged areas of mice hearts in our trials," said Dr. Christian Homsy of Cardio3 Biosciences. "And we are convinced that we can do the same in humans."
- read the report from The Telegraph
Related Articles:
FDA's green light for stem cell trial thrills scientists
Cardio3 garners $17.7M for heart muscle therapy
Geron: Stem cells repair heart attack damage
Comments
Post new comment
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession





SHARE
WITH: